An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1

CompletedOBSERVATIONAL
Enrollment

672

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Hepatitis C, Chronic
Trial Locations (66)

5401

University of Vermont, Burlington

10016

Concorde Medical Group, New York

10467

Montefiore Medical Center, The Bronx

11030

North Shore University Hospital, Manhasset

11215

New York Methodist Hospital, Brooklyn

11355

New Discovery, LLC, Flushing

12414

Mountainview Medical Practice, Catskill

14642

University of Rochester Medical Center, Rochester

15801

DuBois Regional Medical Center, DuBois

19107

Thomas Jefferson University, Philadelphia

19140

Temple University Hospital, Philadelphia

19141

Albert Einstein Medical Center; Division of Hepatology, Philadelphia

21202

Mercy Medical Center; Institute For Digestive Health And Liver Disease, Baltimore

22031

Metropolitan Research, Fairfax

22908

University of Virginia Health System: Gastroenterology at UVA, Charlottesville

27710

Duke Univ Medical Center, Durham

27804

Boice-Willis Clinic, Rocky Mount

28801

Asheville Gastroenterology Associates, P.A., Asheville

30033

Atlanta Center for Gastroenterology, PC, Decatur

Dekalb Gastroenterology Associates, Decatur

31201

Gastroenterology Associates of Central Georgia, Macon

32117

Consultive Medicine, Daytona Beach

32751

Center for Advanced Gastroenterology, Maitland

32806

Internal Medicine Specialists, Orlando

Orlando Infectious Disease Center, Pa, Orlando

33606

Tampa General Hospital; Tampa General Medical Group, Tampa

33777

Florida Center for Gastroenterology, Largo

35233

Cooper Green Hospital, Birmingham

Univ. of Alabama at Birmingham; The Kirklin Clinic, Birmingham

38104

Methodist Heathcare University Hospital, Memphis

41017

Tristate Gastroenerology Associates, Crestview Hills

46237

Indianapolis Gastroenterology, Indianapolis

48201

Harper University Hospital/Wayne State, Detroit

49519

Gastroenterology Associates of Western Michigan, Wyoming

55905

Mayo Clinic Rochester, Rochester

60637

University of Chicago, Chicago

63104

Saint Louis University Gastroenterology & Hepatology; Clinical Research Unit, St Louis

64111

St. Luke's Hospital, Kansas City

64128

Midwest Biomedical Research Foundation, Kansas City

70006

New Orleans Research Institute., Metairie

70809

Ochsner Clinic Foundation, Baton Rouge

72205

Liver Wellness Center, Little Rock

73112

INTEGRIS Baptist Medical Center, Oklahoma City

75203

Methodist Transplant Physicians, Dallas

77005

Kelsey Research Foundation, Houston

77030

Liver Associates of Texas, Houston

77090

Digestive And Liver Disease Consultants, PA, Houston

77555

Univ of Texas Medical Branch, Galveston

78758

Imtiaz Alam MD, P.A. - Private Practice, Austin

80045

University of Colorado Denver, Aurora

90505

South Bay Gastroenterology Medical Group, Torrance

91105

HMRI Liver Center, Pasadena

92154

Kaiser Permanente San Diego; Hepatology Research, San Diego

92161

VA San Diego Healthcare System, San Diego

92354

Loma Linda University Medical Center and Liver Center, Loma Linda

97701

Bend Memorial Clinic, Bend

06790

Litchfield County Gastroenterology Associates, Torrington

70112-2699

Tulane Uni Health Sciences Center, New Orleans

02302

Commonwealth Clinical Studies, Brockton

01199

Baystate Infectious Diseases Clinical Research, Springfield

01068

Partners in Internal Medicine, Worcester

03756

Dartmouth Hitchcock Med Center, Lebanon

08035

Lourdes Medical Associates; Southern New Jersey Center for LIver Disease, Haddon Heights

07960

Atlantic Research Affiliates, Morristown

08234

AGA Clinical Research Associates, LLC, Twp

00927

Fundacion de Investigacion de Diego, San Juan

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01508130 - An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1 | Biotech Hunter | Biotech Hunter